ArticleBriefings in bioinformatics2026
SA-MTP: a structure-aware framework for multifunctional therapeutic peptide annotation.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Therapeutic peptides show many biological activities and are now widely viewed as promising candidates for new drug development. Accurate functional annotation of therapeutic peptides is still difficult. This difficulty comes from their short sequence length, strong structural flexibility, and the presence of multiple biological functions within a single peptide.Here, we introduce Structure-Aware Multi-Label Therapeutic Peptide Predictor (SA-MTP), a structure-aware framework designed for multifunctional annotation of therapeutic peptides. SA-MTP combines pretrained protein language models with a graph attention network to capture sequence semantics and probabilistic structural features. Input-dependent structure-aware graphs are constructed to describe conformational variation, which is especially common in short peptides. Benchmarking experiments across 15 therapeutic function categories were conducted using datasets. The results show that SA-MTP achieves better performance than existing methods across several evaluation metrics, including accuracy, F1-score, and Matthews correlation coefficient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.